No Result

View All Result

No products in the cart.

Home All Specialties Chronic Disease

#VisualAbstract Fondazione Italiana Linfomi (FIL) Phase 3 trial: Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation (HSCT) in mantle cell lymphoma improves progression-free survival (PFS)

byKathleen Lau

January 8, 2021

in Chronic Disease

RELATED REPORTS

Dupilumab and lymphoma risk among patients with asthma: a population-based cohort study

Punjab launches AI screening program this week

2MM: AI Roundup –Lilly launches TuneLab AI drug discovery, smart wound healing bandage, and Punjab cancer screening [September 25th, 2025]

Carboplatin as a potential adjunct therapy for recurrent high-grade glioma treatment

RelatedReports

Evidence-based interventions for pediatric asthma successfully adapted for community health centers

Chronic Disease

Dupilumab and lymphoma risk among patients with asthma: a population-based cohort study

October 13, 2025

Blindness and visual impairment decreasing worldwide

AI Roundup

Punjab launches AI screening program this week

September 30, 2025

AI Roundup

2MM: AI Roundup –Lilly launches TuneLab AI drug discovery, smart wound healing bandage, and Punjab cancer screening [September 25th, 2025]

September 28, 2025

Variation noted across pre- and post-marketing studies for FDA approved devices

AI Roundup

Artificial intelligence accelerates drug discovery and reduces animal testing

September 12, 2025

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

2 Minute Medicine Rewind January 11, 2021

Lansoprazole not effective for the treatment of persistent throat symptoms

#VisualAbstract: Occult Blood in Feces Is Associated With an Increased Risk of Ischemic Stroke and Myocardial Infarction

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result